These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 25668489)

  • 21. Pharmacotherapy with fluoxetine restores functional connectivity from the dentate gyrus to field CA3 in the Ts65Dn mouse model of down syndrome.
    Stagni F; Magistretti J; Guidi S; Ciani E; Mangano C; Calzà L; Bartesaghi R
    PLoS One; 2013; 8(4):e61689. PubMed ID: 23620781
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of voluntary physical exercise on adult hippocampal neurogenesis and behavior of Ts65Dn mice, a model of Down syndrome.
    Llorens-Martín MV; Rueda N; Tejeda GS; Flórez J; Trejo JL; Martínez-Cué C
    Neuroscience; 2010 Dec; 171(4):1228-40. PubMed ID: 20875841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cell cycle alteration and decreased cell proliferation in the hippocampal dentate gyrus and in the neocortical germinal matrix of fetuses with Down syndrome and in Ts65Dn mice.
    Contestabile A; Fila T; Ceccarelli C; Bonasoni P; Bonapace L; Santini D; Bartesaghi R; Ciani E
    Hippocampus; 2007; 17(8):665-78. PubMed ID: 17546680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuroprotective efficacy of aminopropyl carbazoles in a mouse model of Parkinson disease.
    De Jesús-Cortés H; Xu P; Drawbridge J; Estill SJ; Huntington P; Tran S; Britt J; Tesla R; Morlock L; Naidoo J; Melito LM; Wang G; Williams NS; Ready JM; McKnight SL; Pieper AA
    Proc Natl Acad Sci U S A; 2012 Oct; 109(42):17010-5. PubMed ID: 23027934
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Environmental enrichment rescues postnatal neurogenesis defect in the male and female Ts65Dn mouse model of Down syndrome.
    Chakrabarti L; Scafidi J; Gallo V; Haydar TF
    Dev Neurosci; 2011; 33(5):428-41. PubMed ID: 21865665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The polyphenols resveratrol and epigallocatechin-3-gallate restore the severe impairment of mitochondria in hippocampal progenitor cells from a Down syndrome mouse model.
    Valenti D; de Bari L; de Rasmo D; Signorile A; Henrion-Caude A; Contestabile A; Vacca RA
    Biochim Biophys Acta; 2016 Jun; 1862(6):1093-104. PubMed ID: 26964795
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence that increased Kcnj6 gene dose is necessary for deficits in behavior and dentate gyrus synaptic plasticity in the Ts65Dn mouse model of Down syndrome.
    Kleschevnikov AM; Yu J; Kim J; Lysenko LV; Zeng Z; Yu YE; Mobley WC
    Neurobiol Dis; 2017 Jul; 103():1-10. PubMed ID: 28342823
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lifespan analysis of brain development, gene expression and behavioral phenotypes in the Ts1Cje, Ts65Dn and Dp(16)1/Yey mouse models of Down syndrome.
    Aziz NM; Guedj F; Pennings JLA; Olmos-Serrano JL; Siegel A; Haydar TF; Bianchi DW
    Dis Model Mech; 2018 Jun; 11(6):. PubMed ID: 29716957
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lithium restores neurogenesis in the subventricular zone of the Ts65Dn mouse, a model for Down syndrome.
    Bianchi P; Ciani E; Contestabile A; Guidi S; Bartesaghi R
    Brain Pathol; 2010 Jan; 20(1):106-18. PubMed ID: 19298631
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypocellularity in the Murine Model for Down Syndrome Ts65Dn Is Not Affected by Adult Neurogenesis.
    López-Hidalgo R; Ballestín R; Vega J; Blasco-Ibáñez JM; Crespo C; Gilabert-Juan J; Nácher J; Varea E
    Front Neurosci; 2016; 10():75. PubMed ID: 26973453
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Age-related impairment of olfactory bulb neurogenesis in the Ts65Dn mouse model of Down syndrome.
    Bianchi P; Bettini S; Guidi S; Ciani E; Trazzi S; Stagni F; Ragazzi E; Franceschini V; Bartesaghi R
    Exp Neurol; 2014 Jan; 251():1-11. PubMed ID: 24192151
    [TBL] [Abstract][Full Text] [Related]  

  • 32. (-)-P7C3-S243 Protects a Rat Model of Alzheimer's Disease From Neuropsychiatric Deficits and Neurodegeneration Without Altering Amyloid Deposition or Reactive Glia.
    Voorhees JR; Remy MT; Cintrón-Pérez CJ; El Rassi E; Khan MZ; Dutca LM; Yin TC; McDaniel LN; Williams NS; Brat DJ; Pieper AA
    Biol Psychiatry; 2018 Oct; 84(7):488-498. PubMed ID: 29246437
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aerobic exercise and a BDNF-mimetic therapy rescue learning and memory in a mouse model of Down syndrome.
    Parrini M; Ghezzi D; Deidda G; Medrihan L; Castroflorio E; Alberti M; Baldelli P; Cancedda L; Contestabile A
    Sci Rep; 2017 Dec; 7(1):16825. PubMed ID: 29203796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurotherapeutic capacity of P7C3 agents for the treatment of Traumatic Brain Injury.
    Blaya MO; Wasserman JM; Pieper AA; Sick TJ; Bramlett HM; Dietrich WD
    Neuropharmacology; 2019 Feb; 145(Pt B):268-282. PubMed ID: 30236963
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pre- and post-natal melatonin administration partially regulates brain oxidative stress but does not improve cognitive or histological alterations in the Ts65Dn mouse model of Down syndrome.
    Corrales A; Parisotto EB; Vidal V; García-Cerro S; Lantigua S; Diego M; Wilhem Filho D; Sanchez-Barceló EJ; Martínez-Cué C; Rueda N
    Behav Brain Res; 2017 Sep; 334():142-154. PubMed ID: 28743603
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prenatal pharmacotherapy rescues brain development in a Down's syndrome mouse model.
    Guidi S; Stagni F; Bianchi P; Ciani E; Giacomini A; De Franceschi M; Moldrich R; Kurniawan N; Mardon K; Giuliani A; Calzà L; Bartesaghi R
    Brain; 2014 Feb; 137(Pt 2):380-401. PubMed ID: 24334313
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigallocatechin-3-gallate (EGCG) consumption in the Ts65Dn model of Down syndrome fails to improve behavioral deficits and is detrimental to skeletal phenotypes.
    Stringer M; Abeysekera I; Thomas J; LaCombe J; Stancombe K; Stewart RJ; Dria KJ; Wallace JM; Goodlett CR; Roper RJ
    Physiol Behav; 2017 Aug; 177():230-241. PubMed ID: 28478033
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Morphological alterations in the hippocampus of the Ts65Dn mouse model for Down Syndrome correlate with structural plasticity markers.
    Villarroya O; Ballestín R; López-Hidalgo R; Mulet M; Blasco-Ibáñez JM; Crespo C; Nacher J; Gilabert-Juan J; Varea E
    Histol Histopathol; 2018 Jan; 33(1):101-115. PubMed ID: 28374408
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lithium rescues synaptic plasticity and memory in Down syndrome mice.
    Contestabile A; Greco B; Ghezzi D; Tucci V; Benfenati F; Gasparini L
    J Clin Invest; 2013 Jan; 123(1):348-61. PubMed ID: 23202733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Formoterol, a long-acting β2 adrenergic agonist, improves cognitive function and promotes dendritic complexity in a mouse model of Down syndrome.
    Dang V; Medina B; Das D; Moghadam S; Martin KJ; Lin B; Naik P; Patel D; Nosheny R; Wesson Ashford J; Salehi A
    Biol Psychiatry; 2014 Feb; 75(3):179-88. PubMed ID: 23827853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.